SpaceOAR™ Hydrogel

SpaceOAR Vue™ Hydrogel

Absorbable radiopaque perirectal hydrogel spacer

Visibly different

SpaceOAR Vue Hydrogel is the next-generation hydrogel spacer that offers enhanced visibility via CT scan when compared to non-radiopaque spacers.

Interested in streamlining your prostate cancer treatment planning?

Connect with our team to learn more about SpaceOAR Vue Hydrogel, schedule a demo, or get answers to your procedure-related questions.

Experience the next-generation hydrogel

The benefits of SpaceOAR Vue Hydrogel may include:

Optimize dosing plan

With SpaceOAR Vue Hydrogel, physicians may be able to contour the prostate and rectum with a greater degree of confidence without the need for an additional MRI. This may also reduce any contouring inaccuracies, potentially leading to more accurate treatment plan creations.¹

Streamline workflow

Treatment planning can be done using CT only, reducing the need to acquire, reference, and fuse MR and CT images during plan creation. Persistent visibility of SpaceOAR Vue on a kV cone-beam CT is designed to aid in visualization of the target region enabling appropriate patient positioning for radiation treatment.¹

Benefits of radiopacity

The radiopacity may provide a suitable imaging option to MRI for patients with implanted metallic devices.¹

SpaceOAR Vue Hydrogel in different image modalities

T2-weighted Magnetic Resonance images*

Computed Tomography images*

$kV Cone-beam CT image (first fraction).$

kV Cone-beam Computed Tomography image (first fraction)*

$kV Cone-beam Computed Tomography image (last fraction).$

kV Cone-beam Computed Tomography image (last fraction)*

*Jeff Michalski, M.D. [2020]. Permission granted by Washington University Image.

Hear clinicians discuss SpaceOAR Vue Hydrogel’s impact on their practice and their patients

Real-world experience with SpaceOAR Vue Hydrogel

Dr. Elisha Fredman from the Davidoff Cancer Center and Rabin Medical Center in Petah Tikva, Israel shares his clinical experience with SpaceOAR Vue Hydrogel Systems in his prostate cancer therapy approach.

Hear Dr. Fredman's conclusions >
View complete webinar on EDUCARE >

How SpaceOAR Vue can affect workflow

Ed Soffen, M.D., a Radiation Oncologist, talks about the potential benefits of SpaceOAR Vue Hydrogel with easier contouring, better visibility, and time-saving efficiency.

Reaching patients who cannot undergo MRI

Radiation Oncologist, Daniel Petereit, M.D., discusses how SpaceOAR Vue Hydrogel is designed to be highly visible in a CT scan and may be beneficial for patients who cannot undergo an MRI.

Managing patient alignment

Alaina Rizzo, a Radiation Therapist at Princeton Radiation Oncology, talks about how SpaceOAR Vue Hydrogel can help visualize the hydrogel under cone-beam CT to better manage patient alignment.

Meeting dose volume constraints

Joseph Hanley, Ph.D., Director of Medical Physics at Princeton Radiation Oncology, discusses how SpaceOAR Vue Hydrogel had a positive impact on meeting dose-volume constraints of treatment plans.

Get SpaceOAR Vue Hydrogel

Become a certified applier

Connect with a rep

Sign up

Get exclusive updates and clinical data.

Join now

SpaceOAR System Indications, Safety, and Warnings

SpaceOAR Vue Indications, Safety, and Warnings

Reference

Data on file with Boston Scientific.

Caution: U.S. Federal law restricts this device to sale by or on the order of a physician.

CAUTION: The law restricts these devices to sale by or on the order of a physician. Indications, contraindications, warnings, and instructions for use can be found in the product labelling supplied with each device or at www.IFU-BSCI.com. Products shown for INFORMATION purposes only and may not be approved or for sale in certain countries. This material not intended for use in France.

SpaceOAR and SpaceOAR Vue Hydrogels are intended to temporarily position the anterior rectal wall away from the prostate during radiotherapy for prostate cancer and in creating this space it is the intent of SpaceOAR and SpaceOAR Vue Hydrogels to reduce the radiation dose delivered to the anterior rectum.

SpaceOAR and SpaceOAR Vue Hydrogels contain polyethylene glycol (PEG). SpaceOAR Vue Hydrogel contains iodine.

Prior to using these devices, please review the Instructions for Use for a complete listing of indications, contraindications, warnings, precautions and potential adverse events.

As with any medical treatment, there are some risks involved with the use of SpaceOAR and SpaceOAR Vue Hydrogels. Potential complications associated with SpaceOAR and SpaceOAR Vue Hydrogels include, but are not limited to: pain associated with SpaceOAR and SpaceOAR Vue Hydrogels injection, pain or discomfort associated with SpaceOAR and SpaceOAR Vue Hydrogels, local inflammatory reactions, infection (including abscess), urinary retention, urgency, constipation (acute, chronic, or secondary to outlet perforation), rectal tenesmus/muscle spasm, mucosal damage, ulcers, fistula, perforation (including prostate, bladder, urethra, rectum), necrosis, allergic reaction (localized or more severe reaction, such as anaphylaxis), embolism (venous or arterial embolism is possible and may present outside of the pelvis, potentially impacting vital organs or extremities), syncope and bleeding. The occurrence of one or more of these complications may require treatment or surgical intervention. URO-989811-AB.

All trademarks are the property of their respective owners.

My account